News
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc
Form 8.3 - The Vanguard Group, Inc.: Clipper Logistics plc
CI Global Asset Management Announces May 2022 Distributions for CI ETFs
CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending May 31, 2022 in respect of the CI ETFs. In all cases, the distribution will be paid on
Ørsted and TotalEnergies partner to participate in Dutch offshore wind tenders
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hibernian REIT plc
EVRAZ plc: GENERAL LICENCE FOR BASIC NEEDS REQUESTED
Form 8.3 - Maitland Institutional Services Limited: Re RWS Holdings plc
Mannatech Reports First Quarter End 2022 Financial Results
Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2022.
Form 8.3 - Maitland Institutional Services Limited: Re Ideagen plc
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Turkiye Garanti Bankasi A.S.: Prospectus - Summary
DGAP-News: SBF publishes 2021 consolidated financial statements and plans significant growth for 2022
Chelverton UK Dividend Trust plc: Net Asset Value(s)
German Microsoft Ecosystem Cools With Slower IT Spending
German enterprises scaled back some IT investments in the second year of the COVID-19 pandemic, but many are continuing their migrations to cloud platforms, including Microsoft Azure, according to
DGAP-News: Befesa S.A.: Invitation to the Annual General Meeting on 16 June 2022
DGAP-News: Nabaltec AG is winner of the Best Managed Companies Award for the fourth time
DGAP-News: Wüstenrot & Württembergische AG: Operationally, W&W Group starts the year strongly
Poxel Announces Notice of Its Annual General Meeting to Be Held on June 21, 2022
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
DGAP-News: Pyrum Innovations AG receives ISO 9001 certification for its quality management system